Here’s why Citi says crypto prices have been weak recently
Alphatec Holdings Inc. (NASDAQ:ATEC) CEO Miles Patrick sold 100,000 shares of common stock on November 3, 2025, according to a recent SEC filing. The shares were sold at a weighted average price of $18.96, for a total transaction value of $1.89 million. This transaction comes as ATEC shares have surged 114.8% year-to-date and 129.8% over the past year. According to InvestingPro analysis, the stock appears overvalued compared to its Fair Value, with the company currently valued at $2.93 billion.
The prices for the sales ranged from $17.98 to $19.47. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on June 3, 2025. Following the transaction, Patrick directly owns 5,364,078 shares of Alphatec Holdings . Despite posting negative earnings per share of -$1.05, ATEC maintains a "GOOD" overall financial health score according to InvestingPro, with strong revenue growth of 27.1%. Analysts have set price targets ranging from $16 to $25, with comprehensive insights available in the Pro Research Report.
The filing also indicates that Patrick indirectly owns 10,900 shares through an IRA and 250,000 shares through MOM, LLC.
In other recent news, Alphatec Holdings has reported strong third-quarter results, exceeding expectations across various financial metrics. The company recorded a revenue of $197 million, representing a 30% increase compared to the same period last year. Earnings per share also surpassed forecasts, with Alphatec reporting $0.03 against an anticipated loss of $0.04, marking a 175% surprise. Piper Sandler responded to these results by raising its price target for Alphatec to $25, maintaining an Overweight rating. Similarly, Canaccord Genuity increased its price target to $25, up from $20, while keeping a Buy rating, noting the company’s impressive performance. The earnings report highlighted a 31% growth in surgical revenue and a 29% increase in EOS imaging technology revenue. Additionally, Alphatec experienced nearly 30% growth in surgical volume and a 26% rise in new surgeon users. These developments reflect Alphatec’s continued market share gains in the spine surgery sector.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.